Medtech Insight

Inspection Tips Experimentation And Trump

2017 was obviously dominated by news of political chaos coming out of the White House and, for the medtech industry

Topic 2016 US Election

Scrip

Biotech Execs Speak Out Against Trump's Immigration Ban

Letter initiated by six CEOs drew 'absolutely overwhelming' response as 163 leaders of primarily small biotech and venture capital firms signed on; tech firms join court fight.

Topic Press Release 2016 US Election

Scrip

Big Pharma Subdued In Its Response To Trump's Travel EO

Big pharma has been muted in its response to President Trump's executive order imposing severe travel restrictions on nationals from seven Muslim-majority countries for 90 days. Small biotech, however, has no reservations about speaking out against the so-called 'immigration ban'.

Topic Policy & Regulation 2016 US Election

Scrip

IDMA Meet: Trump, Protectionism, New Markets And Cricket

The Trump presidency and the threat of protectionism, new generic opportunities beyond the US market, and the need for new quality benchmarks were some of the key issues discussed at the recent annual day celebrations of the Indian Drug Manufacturers’ Association.

Topic Strategy 2016 US Election

Pink Sheet

Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’

Incoming president not holding over any FDA political appointees from the Obama administration, but what exactly his stamp on the agency will be remains unclear.

Topic FDA 2016 US Election

Scrip

The Bully Pulpit: Trump Versus Drug Prices

Medicare price negotiation is not a new idea – nor is the concept of using the Presidential megaphone to talk down drug prices. Will Trump and Twitter turn it into something bigger?

Topic 2016 US Election

Pink Sheet

The Trump Administration: Seven More Things To Watch Out For

Beyond pricing, industry experts weigh in on how the next administration has shifted expectations across a range of areas – including tax reform, FDA standards and the Cancer Moonshot Initiative.

Topic 2016 US Election

Scrip

Trump’s Rx For The Drug Industry: Take Two And Have No Idea What Will Happen In The Morning

To call the incoming US president unpredictable would be an understatement, but that doesn’t mean that industry shouldn’t know what to expect.

Topic BioPharmaceutical Policy & Regulation 2016 US Election

Medtech Insight

The Unlikely Savior Of 21st Century Cures: Donald Trump

The 21st Century Cures bill made it through the US Congress in 2016 after all; advocates can thank the unexpected presidential victory of Donald Trump for helping to make that happen.

Topic 2016 US Election Policy & Regulation